Optimizing Biologic Therapy in Children with Moderate-to-Severe Atopic Dermatitis: A Series of Expert Panel Discussions Featuring a Parent of an Experienced Patient with AD
Program Information

A Hybrid Satellite Symposium during the 2023 AAAAI Annual Meeting

Registration and Reception
6:30 PM – 7:00 PM CST
Symposium and Panel Discussions
7:00 PM – 8:30 PM CST

Grand Hyatt San Antonio River Walk
Lone Star A, Second Floor

600 E. Market Street
San Antonio, Texas 78205

Also Available to Virtual Attendees via Online Simulcast

Bob Geng, MD

Bob Geng, MD
Voluntary Associate Clinical Professor, Allergy & Immunology
Co-Director, AAFA-sponsored Severe Asthma Program
Rady Children's Hospital
Allergy/Immunology Director, Multidisciplinary Atopic Dermatitis Program
University of California San Diego
President, San Diego Allergy Society
San Diego, CA
Lauren Loop

Lauren Loop
Eczema Educator/Lead Clinical Research Coordinator
Rady Children’s Hospital
Director, Grants and Rare Disease
Allergy and Asthma Medical Group and Research Center
Executive Director, San Diego Allergy Society
San Diego, CA
Reid Oldenburg, MD, PhD

Reid Oldenburg, MD, PhD
Assistant Professor, Department of Dermatology
University of California San Diego
San Diego, CA
Katie Smiley, PA-C

Katie Smiley, PA-C
Clinic Coordinator, Multidisciplinary Atopic Dermatitis Program
Rady Children’s Hospital
San Diego, CA

Atopic dermatitis (AD) typically manifests in infancy and is often the first presenter in a series of type 2 inflammatory diseases commonly referred to as “the atopic march”. While novel therapies have been recently made available for adults and teens, the treatment landscape for infants and children is finally catching up. In this multidisciplinary, interprofessional panel featuring allergists, dermatologists, physicians, a PA, eczema educator, and a parent/guardian of a child with AD, experts will discuss the pathophysiology of AD, new and emerging biologics for pediatric AD, and how to approach AD management with an effective team-based strategy. Attend in-person or via simulcast.

7:00 PM - 7:10 PM CST
7:10 PM - 7:30 PM CST
7:30 PM - 7:55 PM CST
7:55 PM - 8:20 PM CST
8:20 PM - 8:30 PM CST

Dermatologists, allergists/clinical immunologists, and pediatric clinicians

Upon completion of this symposium, participants should be better able to:

  • Identify the role of type 2 inflammation in the pathogenesis of moderate-to-severe atopic dermatitis (AD) and other atopic diseases
  • Apply key data on available and emerging biologic therapies for the treatment of moderate-to-severe AD in children
  • Integrate the unique roles and responsibilities of the interprofessional care team when managing common comorbidities in children with moderate-to-severe AD

This educational activity was independently developed by RMEI Medical Education, LLC. All faculty and planner relevant financial relationships were identified and mitigated and RMEI Medical Education, LLC has reviewed the content and determined it to be fair, balanced, and without commercial bias.

This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.

RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy. RMEI will disclose to learners the presence or absence of relevant financial relationships for all persons in control of content before the learner engages in the education.

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact RMEI prior to the live event at (866) 770-RMEI.

There is no fee for this educational activity.

This program is not certified for continuing education credit.
The content and opinions expressed are those of the provider and/or presenter(s) and are not necessarily those of the AAAAI.

Facebook  Twitter  LinkedIn

Additional educational activities offered by RMEI Medical Education, LLC can be found
at www.RMEI.com or by calling toll-free (866) 770-RMEI.